|
WIZ expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.098570E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.679390E-01 |
| Normal-vs-Stage2 |
4.986200E-01 |
| Normal-vs-Stage3 |
4.699800E-02 |
| Normal-vs-Stage4 |
1.909820E-01 |
| Stage1-vs-Stage2 |
6.393400E-01 |
| Stage1-vs-Stage3 |
2.969800E-01 |
| Stage1-vs-Stage4 |
9.481400E-01 |
| Stage2-vs-Stage3 |
2.759800E-01 |
| Stage2-vs-Stage4 |
6.608000E-01 |
| Stage3-vs-Stage4 |
4.456200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.395800E-02 |
| Normal-vs-AfricanAmerican |
8.601400E-01 |
| Normal-vs-Asian |
8.776200E-01 |
| Caucasian-vs-AfricanAmerican |
2.891400E-01 |
| Caucasian-vs-Asian |
6.474300E-02 |
| AfricanAmerican-vs-Asian |
7.819000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.142800E-01 |
| Normal-vs-Female |
6.865900E-02 |
| Male-vs-Female |
3.322800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.134000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.712000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.277400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.124800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.556800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.082400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.540600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.937400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.590800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.636600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.628300E-02 |
| Classical-VS-Follicular |
2.625900E-02 |
| Classical-VS-Other |
9.157600E-01 |
| Classical-VS-Normal |
4.277000E-01 |
| Tall-VS-Follicular |
7.366000E-01 |
| Tall-VS-Other |
3.960000E-01 |
| Tall-VS-Normal |
2.430200E-02 |
| Follicular-VS-Other |
5.721200E-01 |
| Follicular-VS-Normal |
3.468400E-02 |
| Other-VS-Normal |
6.659800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.002390E-01 |
| Normal-vs-N1 |
8.353600E-02 |
| N0-vs-N1 |
6.721600E-01 |
|
|
